Last reviewed · How we verify
Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks): A Double-blind Randomized-controlled Trial
A double-blind randomized controlled trial to compare a shorter interval between the administration of mifepristone and misoprostol (simultaneous administration compared to 24hours from administration of mifepristone to receipt of the first dose of misoprostol) for termination of pregnancy up to 13-22 weeks of gestation. The investigators hypothesize that a shortened interval may achieve comparable efficacy in terminating pregnancy, whilst reducing the duration of the procedure and in turn, the duration of hospitalization.
Details
| Lead sponsor | Gynuity Health Projects |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 504 |
| Start date | 2013-02 |
| Completion | 2014-05 |
Conditions
- Complete Uterine Evacuation After Use of Study Drugs
Interventions
- Mifepristone
- Misoprostol
Primary outcomes
- Proportion of women who have had a complete uterine evacuation within 24 hours using study drug without recourse to any additional intervention. — Within 1 week
Defined as complete evacuation of fetus and placenta using study drug without recourse to any additional intervention.
Countries
Vietnam